StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 25, 2026, 04:41 PM

Cellectis Shareholders Adopt 29 Resolutions, Reject 1

AI Summary

Cellectis S.A. held its shareholders general meeting on June 25, 2026, in Paris. During the meeting, approximately 55.84% of voting rights were exercised. Shareholders adopted resolutions 1 through 29 and rejected resolution 30, aligning with the recommendations of the board of directors. Detailed results are available on the company's website.

Key Highlights

  • Shareholders meeting held on June 25, 2026, in Paris.
  • Approximately 55.84% of voting rights were exercised.
  • Resolutions 1 through 29 were adopted by shareholders.
  • Resolution 30 was rejected by shareholders.
  • All outcomes were consistent with the Board of Directors' recommendations.